{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T07:38:31Z","timestamp":1692257911240},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T00:00:00Z","timestamp":1420588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1245\/s10434-014-4323-0","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T12:33:15Z","timestamp":1420547595000},"page":"3041-3048","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting HIF1\u03b1 Peri-operatively Increased Post-surgery Survival in a Tongue Cancer Animal Model"],"prefix":"10.1245","volume":"22","author":[{"given":"Soon-Hyun","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doh Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Hui","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Jin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ho","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,7]]},"reference":[{"issue":"Suppl 5","key":"4323_CR1","doi-asserted-by":"crossref","first-page":"v184","DOI":"10.1093\/annonc\/mdq185","volume":"21","author":"V Gregoire","year":"2010","unstructured":"Gregoire V, Lefebvre JL, Licitra L, Felip E. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v184\u20136.","journal-title":"Ann Oncol"},{"key":"4323_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-3284-2-8","volume":"2","author":"M Goerner","year":"2010","unstructured":"Goerner M, Seiwert TY, Sudhoff H. Molecular targeted therapies in head and neck cancer\u2014an update of recent developments. Head Neck Oncol. 2010;2:8.","journal-title":"Head Neck Oncol."},{"key":"4323_CR3","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1586\/era.09.113","volume":"9","author":"F Rivera","year":"2009","unstructured":"Rivera F, Garcia-Castano A, Vega N, Vega-Villegas ME, Gutierrez-Sanz L. Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial. Expert Rev Anticancer Ther. 2009; 9:1421\u20138.","journal-title":"Expert Rev Anticancer Ther."},{"key":"4323_CR4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ctrv.2013.09.007","volume":"40","author":"S Schmitz","year":"2014","unstructured":"Schmitz S, Ang KK, Vermorken J, et al. Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directions. Cancer Treat Rev. 2014;40:390\u2013404.","journal-title":"Cancer Treat Rev."},{"key":"4323_CR5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10147-014-0671-9","volume":"19","author":"M Fujii","year":"2014","unstructured":"Fujii M. Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer. Int J Clin Oncol. 2014;19:220\u20139.","journal-title":"Int J Clin Oncol."},{"key":"4323_CR6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1349-7006.2011.02181.x","volume":"103","author":"JH Mo","year":"2012","unstructured":"Mo JH, Choi IJ, Jeong WJ, Jeon EH, Ahn SH. HIF-1alpha and HSP90: target molecules selected from a tumorigenic papillary thyroid carcinoma cell line. Cancer Sci. 2012;103:464\u201371.","journal-title":"Cancer Sci."},{"key":"4323_CR7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","volume":"8","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liu Y, Malek SN, Zheng P. Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies. Cell Stem Cell. 2011;8:399\u2013411.","journal-title":"Cell Stem Cell."},{"key":"4323_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2011.08.017","volume":"313","author":"M Perez-Sayans","year":"2011","unstructured":"Perez-Sayans M, Suarez-Penaranda JM, Pilar GD, Barros-Angueira F, Gandara-Rey JM, Garcia-Garcia A. Hypoxia-inducible factors in OSCC. Cancer Lett. 2011;313:1\u20138.","journal-title":"Cancer Lett."},{"key":"4323_CR9","first-page":"21","volume":"345","author":"Z Li","year":"2010","unstructured":"Li Z, Rich JN. Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. Curr Top Microbiol Immunol. 2010;345:21\u201330.","journal-title":"Curr Top Microbiol Immunol."},{"key":"4323_CR10","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/00005537-199906000-00025","volume":"109","author":"JL Ku","year":"1999","unstructured":"Ku JL, Kim WH, Lee JH, et al. Establishment and characterization of human laryngeal squamous cell carcinoma cell lines. Laryngoscope. 1999;109:976\u201382.","journal-title":"Laryngoscope."},{"key":"4323_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2005.37.1.1","volume":"37","author":"JL Ku","year":"2005","unstructured":"Ku JL, Park JG. Biology of SNU cell lines. Cancer Res Treat. 2005;37:1\u201319.","journal-title":"Cancer Res Treat."},{"key":"4323_CR12","first-page":"5167","volume":"49","author":"DS Heo","year":"1989","unstructured":"Heo DS, Snyderman C, Gollin SM, et al. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res. 1989;49:5167\u201375.","journal-title":"Cancer Res."},{"key":"4323_CR13","first-page":"1461","volume":"53","author":"S Yasumura","year":"1993","unstructured":"Yasumura S, Hirabayashi H, Schwartz DR, et al. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res. 1993;53:1461\u20138.","journal-title":"Cancer Res."},{"key":"4323_CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1349-7006.2009.01409.x","volume":"101","author":"SH Shim","year":"2010","unstructured":"Shim SH, Lee CT, Hun Hah J, et al. Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma. Cancer Sci. 2010;101:482\u20137.","journal-title":"Cancer Sci."},{"key":"4323_CR15","doi-asserted-by":"crossref","first-page":"20224","DOI":"10.1073\/pnas.1314239110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu J, Pan S, Hsieh MH, et al. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci USA. 2013;110:20224-9.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4323_CR16","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1158\/1078-0432.CCR-08-0376","volume":"14","author":"JS Bono de","year":"2008","unstructured":"de Bono JS, Kristeleit R, Tolcher A, et al. Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors. Clin Cancer Res. 2008;14:6663\u201373.","journal-title":"Clin Cancer Res."},{"key":"4323_CR17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00872868","volume":"13","author":"WJ Gradishar","year":"1995","unstructured":"Gradishar WJ, Vogelzang NJ, Kilton LJ, et al. A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma. An Illinois Cancer Center Study. Invest New Drugs. 1995;13:171\u20134.","journal-title":"Invest New Drugs."},{"key":"4323_CR18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<301::AID-CNCR8>3.0.CO;2-T","volume":"82","author":"AY Chang","year":"1998","unstructured":"Chang AY, Kim K, Boucher H, et al. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587). Cancer. 1998;82:292\u2013300.","journal-title":"Cancer."},{"key":"4323_CR19","doi-asserted-by":"crossref","unstructured":"Wang-Gillam A, Thakkar N, Lockhart AC, et al. A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies. Cancer Chemother Pharmacol. 2014.","DOI":"10.1007\/s00280-014-2493-x"},{"key":"4323_CR20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jc.2013-2558","volume":"99","author":"SH Ahn","year":"2014","unstructured":"Ahn SH, Henderson YC, Williams MD, Lai SY, Clayman GL. Detection of thyroid cancer stem cells in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2014;99:536\u201344.","journal-title":"J Clin Endocrinol Metab."},{"key":"4323_CR21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jcmm.12004","volume":"17","author":"M Mimeault","year":"2013","unstructured":"Mimeault M, Batra SK. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J Cell Mol Med. 2013;17:30\u201354.","journal-title":"J Cell Mol Med."},{"key":"4323_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.oraloncology.2008.03.017","volume":"45","author":"JL Roh","year":"2009","unstructured":"Roh JL, Cho KJ, Kwon GY, et al. The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Oral Oncol. 2009;45:63\u20138.","journal-title":"Oral Oncol."},{"key":"4323_CR23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40265-013-0025-3","volume":"73","author":"K Dorsey","year":"2013","unstructured":"Dorsey K, Agulnik M. Promising new molecular targeted therapies in head and neck cancer. Drugs. 2013;73:315\u201325.","journal-title":"Drugs."},{"key":"4323_CR24","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1158\/0008-5472.CAN-04-0540","volume":"64","author":"DZ Qian","year":"2004","unstructured":"Qian DZ, Wang X, Kachhap SK, et al. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787\/ZK222584. Cancer Res. 2004;64:6626\u201334.","journal-title":"Cancer Res."},{"key":"4323_CR25","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1158\/0008-5472.CAN-05-3962","volume":"66","author":"J Leyton","year":"2006","unstructured":"Leyton J, Alao JP, Da Costa M, et al. In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3\u2032-deoxy-3\u2032-[18F]fluorothymidine positron emission tomography. Cancer Res. 2006;66:7621\u20139.","journal-title":"Cancer Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4323-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4323-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:24:37Z","timestamp":1559633077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4323-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,7]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["4323"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4323-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,7]]}}}